New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Published Jun 18, 2020

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
Fans Pray For Radio Host Dan Bongino After Finishing Cancer treatment
NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
Amid Brain Cancer Battle, Rocker, Tom Parker, 32, Says He Cried Shaving Head After Treatment-Related Hair Loss; Coping with the Effects of Cancer Treatment
NOW
PLAYING
Actress Kristen Bell, 40, Says "I’ve Been Struggling the Last 2 Weeks," Reminding Us Importance of Mental Health; Especially Critical For Those Fighting Cancer
NOW
PLAYING
A Former Paramedic, 48, Is Tragically Diagnosed with Advanced Lung Cancer After an 8-Month Delay to See His Doctor Because of COVID-19

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.